1. Home
  2. CNXN vs IMNM Comparison

CNXN vs IMNM Comparison

Compare CNXN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNXN

PC Connection Inc.

N/A

Current Price

$61.21

Market Cap

1.6B

ML Signal

N/A

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$20.40

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNXN
IMNM
Founded
1982
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
CNXN
IMNM
Price
$61.21
$20.40
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$31.44
AVG Volume (30 Days)
82.3K
1.8M
Earning Date
02-04-2026
11-06-2025
Dividend Yield
0.98%
N/A
EPS Growth
N/A
N/A
EPS
3.24
N/A
Revenue
$2,878,704,000.00
$9,679,000.00
Revenue This Year
$5.85
N/A
Revenue Next Year
$4.52
N/A
P/E Ratio
$18.82
N/A
Revenue Growth
3.19
N/A
52 Week Low
$54.97
$5.15
52 Week High
$75.08
$25.30

Technical Indicators

Market Signals
Indicator
CNXN
IMNM
Relative Strength Index (RSI) 59.51 54.16
Support Level $58.95 $18.81
Resistance Level $61.45 $25.30
Average True Range (ATR) 1.25 1.56
MACD 0.37 0.13
Stochastic Oscillator 85.37 37.75

Price Performance

Historical Comparison
CNXN
IMNM

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: